AzTrials
AzTrials

Trauma-related PTSDNCT05974176

Considering Racial and Acculturation Stress in Addressing Trauma

A study testing Trauma Focused CBT (TF-CBT) and Trauma Systems therapy (TST) in people with Trauma-related PTSD, run by NYU Langone Health at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Investigators plan to offer two evidence based interventions - Trauma Focused Cognitive Behavioral Therapy (CBT) (TF-CBT) and Trauma Systems therapy (TST) to traumatized children and their families. Read more about this study

Who is it for?
Ages 5 to 17 years
Conditions the study is for
Trauma-related PTSD
What is being tested?
Trauma Focused CBT (TF-CBT) and Trauma Systems therapy (TST)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
237 participants
Where
1 siteUnited States
Study dates
1 Jul 2023to 1 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child/adolescent aged 5-17 years of age who has experienced trauma with associated and related emotional dysregulation (i.e PTSD) and one of their parent/guardian
  • Have capacity and willingness to provide consent or age-appropriate assent

Who cannot join

  • Individual with intellectual disability with an IQ<70
  • Individual with active suicidality, homicidality, or other symptoms at the time of enrollment that warrants hospitalization

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • NYU Langone Health

    New York, New York, 10016

    Recruiting

Other trials in United States

About this study

Official title: Evaluating the Effectiveness of Evidence-based Trauma Interventions (Trauma Focused CBT - TF-CBT; and Trauma Systems Therapy - TST), Baseline Index Trauma, and PTSD Symptoms in the Context of Contributing Stress From Racialized Trauma and Acculturation Stress

Investigators plan to offer two evidence based interventions - Trauma Focused Cognitive Behavioral Therapy (CBT) (TF-CBT) and Trauma Systems therapy (TST) to traumatized children and their families. The investigators are looking to evaluate the effectiveness of these interventions in the context of additional stress related to racialized trauma and acculturation stress

Being tested
Trauma Focused CBT (TF-CBT), Trauma Systems therapy (TST)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trauma Focused CBT (TF-CBT)Behavioural

    TF-CBT is an evidence-based treatment for children and adolescents impacted by trauma and their parents or caregivers. It is a components-based treatment model that incorporates trauma-sensitive interventions with cognitive behavioral, family, and humanistic principles and techniques.

  • Trauma Systems therapy (TST)Behavioural

    Trauma Systems Therapy (TST) is focused on the factors that contribute to children and adolescents who experience traumatic stress through the lens of the social context, vulnerabilities, and strengths of the person undergoing treatment.

Study groups in NCT05974176
Study groupRoleWhat they receive
Trauma Focused CBT (TF-CBT)ExperimentalPatients and families randomized to engage in TF-CBT.
Receives: Behavioral: Trauma Focused CBT (TF-CBT)
Trauma Systems therapy (TST)ExperimentalPatients and families randomized to engage in TST.
Receives: Behavioral: Trauma Systems therapy (TST)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Child and Adolescent Trauma Screen (CATS) Score at Baseline

    CATS is a 15-item assessment of potentially traumatic events and of posttraumatic stress symptoms. The total score is the sum of responses and ranges from 0-60; higher scores indicates more symptoms.

    Measured: Baseline (Day 1)

  2. CATS Score at Completion of Intervention

    CATS is a 15-item assessment of potentially traumatic events and of posttraumatic stress symptoms. The total score is the sum of responses and ranges from 0-60; higher scores indicates more symptoms.

    Measured: Completion of Intervention (Typically Month 3-4)

Secondary outcomes (8)
  1. Acculturative Stress Scale (SAFE) Score at Baseline

    SAFE is a 24-item assessment of acculturative stress. Items are rated on a scale from 1 (not at all true) to 4 (very true). The total score is the sum of responses and ranges from 24 to 96; higher scores indicate greater levels of acculturative stress.

    Measured: Baseline (Day 1)

  2. SAFE Score at Completion of Intervention

    SAFE is a 24-item assessment of acculturative stress. Items are rated on a scale from 1 (not at all true) to 4 (very true). The total score is the sum of responses and ranges from 24 to 96; higher scores indicate greater levels of acculturative stress.

    Measured: Completion of Intervention (Typically Month 3-4)

  3. Bidimensional Acculturation Scale (BAS) Score at Baseline

    BAS is a 24-item assessment of bidimensional acculturation. Items are rated on a 4-point scale. The total score is the sum of responses and ranges from 24 to 96; higher scores indicate higher levels of bidimensional acculturation.

    Measured: Baseline (Day 1)

  4. BAS Score at Completion of Intervention

    BAS is a 24-item assessment of bidimensional acculturation. Items are rated on a 4-point scale. The total score is the sum of responses and ranges from 24 to 96; higher scores indicate higher levels of bidimensional acculturation.

    Measured: Completion of Intervention (Typically Month 3-4)

  5. Multi-Group Ethnic Identity Measure (MEIM-6) Score at Baseline

    6-item questionnaire to assess the degree of ethnic identity among adolescents. Each item is rated on a scale from 1 (strongly disagree) to 5 (strongly agree). The total score is the sum of responses and ranges from 6 to 30; higher scores indicate greater ethnic identify.

    Measured: Baseline (Day 1)

  6. Multi-Group Ethnic Identity Measure (MEIM-6) Score at Completion of Intervention

    6-item questionnaire to assess the degree of ethnic identity among adolescents. Each item is rated on a scale from 1 (strongly disagree) to 5 (strongly agree). The total score is the sum of responses and ranges from 6 to 30; higher scores indicate greater ethnic identify.

    Measured: Completion of Intervention (Typically Month 3-4)

  7. Trauma Symptoms of Discrimination Scale (TSDS) at Baseline

    21-item questionnaire assessing trauma symptoms of discrimination. Each item is rated on a scale from 1 (never) to 4 (often). The total score is the sum of responses and ranges from 21 to 84; higher scores indicate greater symptoms.

    Measured: Baseline (Day 1)

  8. Trauma Symptoms of Discrimination Scale (TSDS) at Completion of Intervention

    21-item questionnaire assessing trauma symptoms of discrimination. Each item is rated on a scale from 1 (never) to 4 (often). The total score is the sum of responses and ranges from 21 to 84; higher scores indicate greater symptoms.

    Measured: Completion of Intervention (Typically Month 3-4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2023
  2. Study start1 Jul 2023
  3. Primary completion1 Aug 2027 (estimated)
  4. Study completion1 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
237 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05974176
Sponsor's protocol ID
23-00094
Status last verified
May 2026
First submitted
26 Jul 2023
Last updated
29 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Shared only with study team.

Questions about this trial

What is this clinical trial studying?

A study testing Trauma Focused CBT (TF-CBT) and Trauma Systems therapy (TST) in people with Trauma-related PTSD, run by NYU Langone Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aaron Reliford (646-594-8895, Aaron.reliford@nyulangone.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Child and Adolescent Trauma Screen (CATS) Score at Baseline (time frame: Baseline (Day 1)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in